Randomized Clinical Trial of Intravenous Valproate (Orifil) and Dexamethasone in Patients with Migraine Disorder

Authors

  • Fahimeh Ahmadi Department of Neurology, Mashhad University of Medical Sciences, Mashhad, Iran
  • Kavian Ghandehari Cerebrovascular Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
  • Keyvan Shariatinezhad Department of Biostatistics, Mashhad University of Medical Sciences, Mashhad, Iran
  • Kosar Ghandehari Cerebrovascular Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
  • Mohsen Foroughipour Department of Neurology, Mashhad University of Medical Sciences, Mashhad, Iran
  • Mojtaba Khazaei Department of Neurology, Mashhad University of Medical Sciences, Mashhad, Iran
Abstract:

Background: Intravenous Valproate (IVVP) has been used in the treatment of migraine in some studies; however, it is far better known in the management of status epilepticus. Methods: Consecutive patients with migraine in our Headache Clinic were enrolled in this prospective, randomized clinical trial in 2011. The patients were randomized into two therapeutic groups, one receiving 900 mg IVVP (Orifil) and the other 16 mg IV Dexamethasone (IVDEX) diluted in 150 CC normal saline and infused for 10 minutes. Worst severity of pain before treatment and least severity at 3 hours after the infusion using a 0-10 point numeric rating scale were recorded. An interview with the patient was performed 72 hours after treatment to detect a possible relapse of headache. Results: Thirty-one migraine status patients, comprising 28 women and 3 men at a mean±SD age of 33.355±12.373 SD, were investigated. Differences in the therapeutic effects of IVVP (Orifil) and IVDEX on pain score were not significant between the two groups (t=0.933, df=29; P=0.358). Relapse of headache occurred in 68.42% of the IVVP (Orifil) group and 66.67% of the IVDEX group. Distribution of relapse was not significantly different between the two therapeutic groups of patients (P=0.870). Conclusion: IVVP (Orifil) was similar in efficacy to IVDEX as abortive therapy in patients with migraine status. IVVP (Orifil) appears to offer a safe and well-tolerated abortive treatment. Trial Registration Number: IRCT13891146234N2

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

randomized clinical trial of intravenous valproate (orifil) and dexamethasone in patients with migraine disorder

background: intravenous valproate (ivvp) has been used in the treatment of migraine in some studies; however, it is far better known in the management of status epilepticus. methods: consecutive patients with migraine in our headache clinic were enrolled in this prospective, randomized clinical trial in 2011. the patients were randomized into two therapeutic groups, one receiving 900 mg ivvp (o...

full text

Comparison between Intravenous Sodium Valproate and Subcutaneous Sumatriptan for Treatment of Acute Migraine Attacks; Double-Blind Randomized Clinical Trial

Background: Sodium valproate (SV) has been approved for migraine prophylaxis and its intravenous form is used to treat acute migraine attacks. We compared the efficacy and safety of intravenous SV and subcutaneous Sumatriptan in managing acute migraine attacks. Methods: This double-blind randomized clinical trial divided 90 patients into two groups: one group received 400 mg of intravenous SV a...

full text

Effect of Intravenous Sodium Valproate vs Dexamethasone on Acute Migraine Headache: A Double Blind Randomized Clinical Trial

BACKGROUND Despite the impact of sodium valproate and dexamethasone on migraine headache, the efficacy of the two drugs has not been properly investigated and compared. This trial compared the effect of the two drugs on acute migraine headache. METHODS This double blind randomized clinical trial was conducted on patients aged 18 to 65 years with acute migraine headache who referred to the eme...

full text

Clinical Trial of Subcutaneous Steroid Injection in Patients with Migraine Disorder

Background: Neurologic literature on therapeutic effect of subcutaneous corticosteroids in patients with migrainous chronic daily headache is scarce. The aim of this research is to assess the therapeutic effects of this management in such patients.Methods: Consecutive patients with migrainous chronic daily headache enrolled a prospective before-after therapeutic study during 2010-2013. Methylpr...

full text

The Effect of Aromatherapy with Lavender Essence on Depression and Headache Disability in Migraine Patients: A Randomized Clinical Trial

Background: Disability due to headache in migraine and being chronic of it can lead to sadness and depression. Objective: This study was aimed to determine the effect of lavender aromatherapy on depression and headache disability. Methods: This clinical trial study was conducted on 60 migraine patients referred to Toba Clinic of Sari (Mazandaran, Iran) during 2016-2017. Patients in the experi...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 38  issue June Supplement 2013

pages  150- 155

publication date 2013-06-01

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023